Company intelligence / Profile preview

Concord IP2

Ahmedabad, Gujarat, India

Ownership: Private
Employees: ~1200
Development stage: Other

Overview

Concord Biotech is a leading supplier of fermentation-based and semi-synthetic APIs and formulations with more than 23 commercial API products. It holds over 20% global market share in several fermentation-based APIs, with extensive regulatory filings across regulated markets. Products are marketed and commercialized in more than 70 countries worldwide[2][1][7].

Therapeutic areas: OncologyImmunologyInfectious DiseasesNephrology
Modalities: Small moleculeBiologicPeptides
Industry: Biotech

Partnerships

Global pharmaceutical companies (undisclosed)

Beyond the preview

Go deeper on Concord IP2.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Concord IP2.

Explore the full profile